Genprex, Inc. — Form 8-K
Filed August 5, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
On August 4, 2026, Genprex, Inc. (market cap ~$7.5M) received notice of failure to satisfy continued listing standards and potential delisting from its exchange. Item 3.01 indicates notice of delisting or transfer of listing. No specific remediation timeline, financial metrics, or counterparty details are disclosed in this filing.
Why this rating
Delisting is existential threat to micro-cap biotech; eliminates public market access, severely impairs fundraising, investor confidence, and operations—business-altering for $7.5M company.
Extracted items
- 3.01 delisting notice
- 9.01 exhibits
See more from August 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.